
CATrends: Celebrities Deceptively Promoting Cryptoassets
A-listers face lawsuits over promotions of risky and unregulated investments.
Lomedico et al. v. American Behavioral Research Institute LLC, d/b/a Relaxium
22-cv-6097, S.D.N.Y.
(July 2022)
Relaxium
Misleadingly marketing that the supplement is a “clinically proven” sleep aid when the only scientific study conducted on the product was inadequate and sponsored by Relaxium
Falsely advertising that the supplement was developed by a “sleep expert” when he has no experience or background in treating sleep disorders
A-listers face lawsuits over promotions of risky and unregulated investments.
Complaints against additional distributors who hosted COVID webinars may be forthcoming.
TINA.org files comment in support of applying rule to direct selling industry.
Even celebs have FOMO
Don’t Be Like Mike and get an FDA/FTC warning letter regarding COVID claims.